WASHINGTON — Eight months ago, EPA Administrator Lee Zeldin stood at the precipice of a political firestorm. Faced with a burgeoning petition from "Make America Healthy Again" (MAHA) activists demanding his resignation, Zeldin made a tactical pivot: he pledged to codify the movement’s priorities into a formal, binding agenda. This document was intended to serve as a roadmap for sweeping federal action against toxic chemicals, pesticides, and the environmental drivers of America’s chronic disease epidemic.
Today, that document is nowhere to be found.
What was once promised as a cornerstone of the Trump administration’s environmental health policy has dissolved into an amorphous, ongoing "effort." As the EPA abandons the prospect of a formal report, the move has ignited a volatile rift between the administration and the very coalition that President Donald Trump credits with his return to the White House. For the activists who mobilized voters around the promise of a toxic-free future, the administration’s silence is being interpreted as a betrayal—one that could have profound consequences for the upcoming midterm elections.
A Chronology of Broken Promises
The descent from optimism to disillusionment began in December of the previous year. Under immense pressure from the MAHA coalition—a diverse group of health advocates, parents, and agricultural reformers—Zeldin sought to quell dissent by promising a transparent, actionable agenda.
- December: In response to a Change.org petition, Zeldin commits to drafting a "MAHA Agenda" to address environmental health concerns.
- Spring: The EPA repeatedly assures stakeholders and the press that the report is in its "final stages" of development.
- April: In an attempt to showcase progress, Zeldin publicly lists microplastics and pharmaceuticals as potential targets for regulation under the Safe Drinking Water Act.
- June: The EPA quietly reverses course, excluding those same contaminants from a mandatory testing program, citing technical limitations.
- August: The agency officially pivots, informing the press that the "MAHA agenda" is not a document, but a philosophy of governance.
This timeline reflects a strategic retreat. By reframing a concrete policy document as an abstract "ongoing effort," the EPA has effectively insulated itself from the charge that it has failed to deliver on its specific, documented promises.
The Regulatory Rollback: A Paradox of Governance
The frustration within the MAHA movement is not merely about a missing report; it is rooted in a fundamental disconnect between the rhetoric of "health" and the reality of the EPA’s actions under Zeldin’s leadership. Zeldin, who frequently refers to the agency as "Trump’s EPA," has presided over what he describes as "the greatest day of deregulation our nation has seen."
The administration has moved aggressively to dismantle decades of environmental safeguards. Most notably, Zeldin proposed overturning the scientific consensus that climate change represents a threat to human health, a move that critics argue undermines the very foundation of environmental regulation. Furthermore, the agency has frozen billions in clean energy funding and shuttered or redirected significant portions of internal research.
For activists, these actions represent a "slap in the face." Kelly Ryerson, an activist and founder of the "Glyphosate Girl" social media presence, notes that while her network successfully collaborated with the administration on an executive order for regenerative agriculture, the win was short-lived. "They used the executive order as a justification to authorize new, more intensive uses for various herbicides," Ryerson said. "We haven’t had any of the wins that we were requesting. Instead, we have seen the expansion of the very toxins we are trying to eradicate."
Corporate Capture and the "Revolving Door"
At the heart of the MAHA movement’s grievance is the staffing of the EPA. Critics argue that the agency has become a haven for industry insiders, effectively neutralizing any grassroots pressure for reform.
The appointment of Kyle Kunkler—a former lobbyist for the soybean industry—to lead pesticide policy has become a flashpoint. Under his tenure, the EPA has continued to allow the use of dicamba, a herbicide linked to significant ecological damage and increased cancer risks in certain populations.
Similarly, the presence of Nancy Beck and Lynn Dekleva, both former executives at the American Chemistry Council, in key leadership positions within the Office of Chemical Safety and Pollution Prevention, has fueled accusations of corporate capture. While the EPA maintains that these appointees have consulted with ethics officials to mitigate conflicts of interest, activists like Zen Honeycutt of Moms Across America argue that the policy outcomes speak for themselves. "This is exactly what happens when the EPA allows itself to be pressured by corporations rather than the public," Honeycutt said.
The Data Gap: Where Did the Science Go?
The administration’s refusal to follow through on testing for microplastics and pharmaceuticals in drinking water serves as a case study in the current EPA’s approach to science. In April, the agency garnered headlines by including these substances on a potential regulatory list. By June, however, that momentum had vanished.
The EPA’s defense—that "the technology to test and treat for microplastics in drinking water is still in development"—has been met with skepticism by former agency experts. Betsy Southerland, a veteran of the EPA’s water office, characterized the reversal as "functionally toothless."
"They made a big splash in the press to appease the MAHA base," Southerland noted. "Then, once the news cycle moved on, they quietly stalled that momentum. It is a classic move to avoid the costs associated with actual regulation."
The irony is that a White House-commissioned report, released earlier in the term, explicitly identified long-term exposure to chemicals found in plastics as a leading cause of chronic disease in children. By ignoring its own research, the administration has placed itself in a position of direct conflict with its own internal findings.
Political Implications: The Midterm Calculus
As the November midterms approach, the political stakes are rising. The MAHA movement, which helped secure the White House for the Trump administration, is now warning that its members are prepared to vote on issues rather than party lines.
"People are done with the profits of corporations being prioritized over public health," said molecular toxicologist Alexandra Muñoz. "The administration thinks they can keep us on the hook with promises and press releases, but I think this will have a major role in the midterms. Voters are paying attention to the disconnect between the talk and the walk."
For the Republican establishment, the danger is that the MAHA coalition represents a critical voting bloc in key swing districts—voters who are deeply skeptical of mainstream political narratives and highly motivated by health and environmental issues. By failing to deliver the "MAHA agenda," the administration risks alienating this base at a time when turnout is paramount.
Official Response: The EPA’s Defense
In response to inquiries regarding the missing agenda, an EPA spokesperson maintained that the agency’s work is both robust and active. "The notion that MAHA is a single document waiting to be unveiled fundamentally misrepresents how we operate," the spokesperson stated via email.
The agency pointed to $945 million in grants designed to help communities combat PFAS (per- and polyfluoroalkyl substances) in drinking water and the identification of 30 drinking water contaminants proposed for nationwide monitoring as evidence of their commitment. Furthermore, the agency highlighted a new inter-departmental initiative involving the Department of Health and Human Services and the USDA, aimed at protecting consumers from heavy metals in the food supply.
However, for those within the MAHA movement, these figures and initiatives are viewed as insufficient—a "diversionary tactic" meant to placate the public while the agency continues its broader deregulatory agenda.
Conclusion: A Movement at a Crossroads
The tension between the EPA and the MAHA movement is a microcosm of a larger national debate: whether the federal government should prioritize the growth and deregulation of private industry or the protection of public health.
As the promised agenda remains a phantom, the activists who once marched under the banner of "Make America Healthy Again" are finding that their influence has limits. Whether they choose to abandon the party or double down on their efforts to hold the administration accountable remains to be seen. For now, the silence from the EPA speaks volumes, leaving the movement in a state of growing frustration—and setting the stage for a contentious political autumn.
